Share statistics (as at 21 March 2017)
|Number of Ordinary Shares in issue (undiluted)||120,628,682|
|Number of Ordinary Shares subject to options||5,197,500|
|Maximum number of Ordinary Shares in issue (fully diluted)||125,826,182|
The effect of the options, if all were exercised, would be to increase the issued share capital by 4.31% and raise £2,762,638 for the Company.
There are no restrictions on the transfer of Futura Medical plc shares.
Major shareholders (as at 5 April 2017)
Shareholders holding more than 3% of the share capital of Futura were:
|Lombard Odier Asset Management (Europe) Limited||19.3%|
|Octopus Asset Management||7.9%|
|WT Lamb Investments Limited||3.9%|
|Medinvest Holdings Limited||3.5%|
Shares not in public hands (as at 21 March 2017)
In terms of the AIM Rules and insofar as it is aware, 21.04% of the Company's AIM securities are not in public hands.
Shares held in treasury (as at 21 March 2017)
In terms of the AIM Rules, there are no shares held in treasury.
Share volumes (as at 21 March 2017)
The daily average number of shares traded since 2012 is:
|Daily Average Per Year Since 2012 ('000)||Daily Average Per Month in 2017 ('000)|
Share options (as at 21 March 2017)
The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:
|Grant||Exercise period (incl)||Exercise price/share||No of share options granted||Cash to Company on exercise|
|7/10||8/12 - 7/17||40.50p||100,000||£40,500|
|9/11||10/13 - 9/18||56.50p||627,500||£354,538|
|9/12||10/14 - 9/19||61.50p||660,000||£405,900|
|9/13||10/15 - 9/20||71.50p||750,000||£536,250|
|9/14||10/16 - 9/21||51.75p||740,000||£382,950|
|9/15||10/17 - 9/22||30.00p||1,060,000||£318,000|
|1/17||10/18 - 9/23||57.50p||1,260,000||£724,500|
Further details of share options issued can be obtained from the Company's Annual Report 2015 which can be found in the Annual and Interim Reports section.
Page last updated: 6 April 2017